Jun 11, 2015
Labcyte Inc. and the Institute for Molecular Medicine Finland (FIMM) of the University of Helsinki, announced today the extension of a collaboration that began in 2013 centering on the use of Labcyte’s Echo® liquid handlers for new personalized medicine strategies to treat cancer patients.
May 28, 2015Labcyte Introduces Reservoir Plate for Echo 525 Liquid Handler to Facilitate High-Throughput, Large Volume Reagent Transfers for Genomic, Proteomic and Cell-based Assays
Labcyte Inc., a company revolutionizing life science research with its patented acoustic liquid handling technology, today announced expanded capabilities for the Echo® 525 liquid handler with the introduction of the Echo qualified reservoir, a liquid handler source plate designed to enable convenient assay assembly and efficient large volume reagent transfers. The reservoir enables scientists performing genomic, proteomic and cell-based assays to reduce the use of costly reagents while achieving rapid fluid transfers.
May 5, 2015
Oxford Finance LLC ("Oxford"), a specialty finance firm that provides senior debt to life sciences and healthcare services companies, and Silicon Valley Bank today announced the closing of a credit facility, including a $10 million senior secured term loan and a $7 million line of credit, with Labcyte Inc. Labcyte is a global biotechnology tools company that is revolutionizing life science research with its patented acoustic liquid handling technology. Proceeds of the loan will be used to support Labcyte's research and development efforts and the expansion of its worldwide business.
Apr 29, 2015
Labcyte Inc., a company revolutionizing life science research with its patented acoustic liquid handling technology, congratulates Dr. Jonathan Wingfield, Associate Principal Scientist, Discovery Sciences, Screening Sciences and Sample Management at AstraZeneca for receiving the Innovation Award and a $10,000 prize at SLAS2015, the annual conference and exhibition of the Society for Laboratory Automation and Screening (SLAS), held Feb. 7-11 in Washington D.C. His presentation, now available for viewing on the SLAS website (http://www.slas.org/slas2015-webinar/), is titled “Novel Acoustic Loading of a Mass Spectrometer — Towards Next Generation High Throughput MS Screening.”
Feb 10, 2015
Labcyte, the company revolutionizing life science research with its patented acoustic liquid handling technology, today praised the results of an international collaboration between the Institute for Molecular Medicine Finland (FIMM), University of Helsinki and the pharmaceutical company Pfizer. The research, described on 9 February, 2015, in the journal Nature1, identified a previously unrecognized action of Pfizer’s axitinib as a potent inhibitor of the dominant mutation that confers drug resistance to all well tolerated treatments in patients with certain types of leukemia.
Feb 9, 2015
Labcyte Inc., the company revolutionizing life science research with the Echo® liquid handler, today announced the appointment of Chris Grimley as Vice President of Marketing. Mr. Grimley will be responsible for leading the global marketing and product management teams, driving demand for products and services, and growing sales of the Echo liquid handler in emerging application areas such as in synthetic biology, next generation sequencing and personalized medicine.